# Octapharma AB - Inspection Records

Source: https://www.globalkeysolutions.net/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262

> Inspection records and compliance data for Octapharma AB in Stockholm, None. Access full analysis and detailed observations.

---

## Details

- Name: Octapharma AB
- FEI Number: 3005559915
- City: Stockholm
- State: None
- Country Name: Sweden
- Address Line 1: Lars Forssells Gata 23
- Zip Code: None

## Related Documents

- [483 - Octapharma AB - 2023-09-19](https://www.globalkeysolutions.net/records/483/octapharma-ab/39c0cc19-3c92-4f74-935f-51aa7ab303f4) — source: FDA, date: September 19, 2023
- [FDA Inspection 1218250 - Octapharma AB - 2023-09-19](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-ab/3645f477-d675-40fc-90b8-3704a595408d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2023
- [FDA Inspection 1070173 - Octapharma AB - 2018-09-28](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-ab/d1bd9bce-fbba-4979-be9f-74a49e7eed87) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 28, 2018
- [FDA Inspection 894095 - Octapharma AB - 2014-04-28](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-ab/b353da3f-7e1b-492d-8bed-ece62fb5761e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2014
- [FDA Inspection 783783 - Octapharma AB - 2012-01-19](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-ab/1a09a3bb-de0f-4a67-b7be-e990f830f4fa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2012
- [FDA Inspection 710676 - Octapharma AB - 2011-01-20](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-ab/e46fa3b2-794a-456e-97d5-2b973b8e1194) — classification: Official Action Indicated (OAI), source: FDA, date: January 20, 2011
- [FDA Inspection 580664 - Octapharma AB - 2009-01-29](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-ab/aecdcdae-81fa-4620-9ef5-96c6d77149d6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2009

## Related Companies

- [BioDuro, LLC](https://www.globalkeysolutions.net/companies/bioduro-llc/ea6debd9-54f2-4570-a8b6-f62b6f60c207)
- [Summit Biosciences Inc.](https://www.globalkeysolutions.net/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976)
- [AstraZeneca Nijmegen B.V.](https://www.globalkeysolutions.net/companies/astrazeneca-nijmegen-bv/29dc14a3-b8e5-4e0a-9399-8d18afc9d686)
- [Colgate-Palmolive Company](https://www.globalkeysolutions.net/companies/colgate-palmolive-company/7db665f6-094f-4de5-bf3b-c2528e2a223b)
- [Haleon US Holdings LLC](https://www.globalkeysolutions.net/companies/haleon-us-holdings-llc/adf0ad1b-ed79-4d72-a254-d42d5a982384)
- [Mipharm S.p.A.](https://www.globalkeysolutions.net/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc)
- [Qilu Pharmaceutical (Hainan) Co. Ltd.](https://www.globalkeysolutions.net/companies/qilu-pharmaceutical-hainan-co-ltd/60dedaab-e32c-493a-894b-9eec7372c066)
- [Nostrum Laboratories, Inc.](https://www.globalkeysolutions.net/companies/nostrum-laboratories-inc/c9042755-fe46-4113-b071-6c8168af53e2)
- [Mayne Pharma International PTY LTD](https://www.globalkeysolutions.net/companies/mayne-pharma-international-pty-ltd/073fd71d-43f6-4a53-9597-0951e7459d08)
- [PF Soins de Sante SRI](https://www.globalkeysolutions.net/companies/pf-soins-de-sante-sri/9e60bbed-a0ce-4353-ae08-a599608d5bd4)

## Related Officers

- [Scott T. Ballard](https://www.globalkeysolutions.net/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [Olga Simakova](https://www.globalkeysolutions.net/people/olga-simakova/2ee5985e-425e-4732-8869-2be861f5d792)